-
Featured
New Clues Emerge on Management of Recurrent Nonmuscle Invasive Bladder Cancer After Trimodality Therapy
When nonmuscle invasive bladder cancer develops after trimodality therapy for muscle invasive bladder cancer, salvage radical cystectomy isn't necessarily required, researchers have found.
-
Featured
Modified Paclitaxel Plus Daily Radiation Helps Noncystectomy Candidates
Physicians at Massachusetts General Hospital are in the early stages of testing a novel regimen for patients with muscle-invasive urothelial bladder cancer who are medically unfit for radical cystectomy or platinum-based radiosensitizing chemotherapy.
-
Featured
Orthotopic Neobladder Reconstruction Restores Quality of Life for Female Cystectomy Patients
Orthotopic neobladder reconstruction is becoming the diversion procedure of choice for female cystectomy patients due to recent advances in care for female urology patients.
-
SRPK2 May Have Key Role in Prostate Cancer Progression and Metastasis
Urologists have demonstrated for the first time that SRPK2, a cell-cycle regulator protein, is upregulated in human prostate cancer and contributes to disease progression and metastasis.
-
Aromatase Expression in Bladder Tumors is Associated with Cancer Progression
Scientists at Mass General have demonstrated that aromatase in bladder tumors is involved in disease progression and may be a prognostic factor.
-
Advances in the Pathophysiology, Potential Treatment of Interstitial Cystitis
Using a mouse model of interstitial cystitis, researchers have newly identified an IL-33/mast cell axis in the bladder, suggesting how novel treatments might be developed for this painful, debilitating condition.
Bladder contributors
-
Chin-Lee Wu, MD, PhD
Associate Pathologist, Massachusetts General Hospital, Associate Professor of Pathology, Harvard Medical School, Director, Genitourinary Pathology Services
Recent Article
SRPK2 May Have Key Role in Prostate Cancer Progression and Metastasis -
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Associate Professor, Harvard Medical School
Recent Article
Noninvasive Assay Predicts Drug Response, Early Dissemination in Prostate Cancer
-
Jason A. Efstathiou, MD, Dphil
Director, Genitourinary Service, Department of Radiation Oncology, Clinical Co-Director, The Claire and John Bertucci Center for Genitourinary Cancers Multidisciplinary Clinic
Recent Article
New Clues Emerge on Management of Recurrent Nonmuscle Invasive Bladder Cancer After Trimodality Therapy -
Marc Dror Michaelson, MD, PhD
Clinical Director, Genitourinary Cancer Center
Recent Article
Modified Paclitaxel Plus Daily Radiation Helps Noncystectomy Candidates -
Matthew F. Wszolek, MD
Assistant in Urology, Massachusetts General Hospital, Instructor in Surgery, Harvard Medical School
Recent Article
New Clues Emerge on Management of Recurrent Nonmuscle Invasive Bladder Cancer After Trimodality Therapy
-
Michael L. Blute, MD
Chief, Department of Urology, Walter S. Kerr, Jr., Professor of Surgery, Harvard Medical School
Recent Article
Orthotopic Neobladder Reconstruction Restores Quality of Life for Female Cystectomy Patients
-
William Shipley, MD
Andres Soriano Distinguished Professor of Radiation Oncology, Harvard Medical School
Recent Article
Modified Paclitaxel Plus Daily Radiation Helps Noncystectomy Candidates
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.Resource Links
